Featured Research

from universities, journals, and other organizations

Restoring trust vital in public acceptance of the use of residual newborn screening specimens

Date:
June 14, 2011
Source:
University of Michigan Health System
Summary:
Government guidelines on the use of dried blood spots collected during mandatory newborn screening underemphasize the importance of getting the public on board with the practice, according to one researcher.

Government guidelines published June 14on the use of dried blood spots collected during mandatory newborn screening underemphasize the importance of getting the public on board with the practice, according to University of Michigan researcher.

Educating the public about the value of research on newborn blood as well as asking parents their preference on the storage and use of specimens would go a long way in eliminating government mistrust and opposition to the practice of using newborn blood for valuable research, says Beth A. Tarini, M.D., M.S., a faculty member with the Child Health Evaluation and Research (CHEAR) Unit at the University of Michigan, in a commentary available online June 14 ahead of print in the journal Genetics in Medicine.

The journal is the official, peer-reviewed journal of the American College of Medical Genetics.

Throughout the U.S., state law mandates that newborns be tested shortly after birth for treatable, endocrinologic, metabolic and hematologic diseases.

According to the U.S. Centers for Disease Control, approximately 3,000 babies with severe disorders are identified in the United States each year using newborn screening programs.

In some states, after screening has been completed, the samples are used for research aimed at improving the health of the population -- such as studying exposures to environmental toxins during pregnancy and early childhood. The majority of the general public has little understanding of the benefits of using these stored blood samples for research purposes.

The new recommendations by the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children recommendations come after extensive investigation and deliberation involving international and national experts in newborn screening, public health and law, and members of the general public.

The guidelines focus heavily on the legal and ethical procedures that states must follow to permit research using these specimens. But they fall short in addressing the public's increasing apprehension about residual dried blood spots storage and use -- especially public concerns about privacy and potential government misuse of samples.

Especially in light of two lawsuits, claiming research use of sample specimens violated privacy laws, were filed in 2009.

Filed by families in Minnesota, the first lawsuit alleged that storage and use of DBS violated in the state's Genetic Privacy Act. It was dismissed by the court, claiming that the Act was not applicable to the NBS program. The second lawsuit, filed against the Texas State Department of Health by families who claimed storage and use of NBS for undisclosed research purposes violated their constitutional protection from unlawful search and seizure. The case was settled.

Much of the mistrust is rooted in public rhetoric that claims that samples may be used to ration healthcare or create a government DNA database for tracking citizens, says Tarini, M.D., M.S., also a pediatrician at U-M C.S. Mott Children's Hospital.

"These claims are unfounded and, in some cases, represent a co-opting of these issues for broader political agendas," Tarini explains in her commentary.

However, these claims can easily pollute public opinion when the public is not properly educated about the use of specimens and when suspicion is fueled by government mistrust, warns Tarini.

In order to prevent the spread of fear and misinformation regarding specimen use and storage, Tarini stresses that the health care community should engage the public and explain the value of the specimens as a promising resource for the public good.

"Although the value of the specimens may be forgone conclusions to those of us who work in public health…it is likely not that way for the general public," Tarini adds.

Tarini urges that educating the public on these benefits is critical. "The real challenge lies in getting the public to believe in these processes and the value of studying these specimens."

According to Tarini, the most effective way to foster trust and lessen public concern may be to give parents the ability to consent to the use of their child's specimens for research use, as the state of Michigan has done.

"Paradoxically, it is likely that allowing parents the opportunity to say no may actually get them to say yes," Tarini concludes.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Restoring trust vital in public acceptance of the use of residual newborn screening specimens." ScienceDaily. ScienceDaily, 14 June 2011. <www.sciencedaily.com/releases/2011/06/110614203623.htm>.
University of Michigan Health System. (2011, June 14). Restoring trust vital in public acceptance of the use of residual newborn screening specimens. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/06/110614203623.htm
University of Michigan Health System. "Restoring trust vital in public acceptance of the use of residual newborn screening specimens." ScienceDaily. www.sciencedaily.com/releases/2011/06/110614203623.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins